MECHANISM OF HUMAN LYMPHOTOXIN AND TUMOR-NECROSIS-FACTOR INDUCED DESTRUCTION OF CELLS-INVITRO - PHOSPHOLIPASE ACTIVATION AND DEACYLATION OF SPECIFIC-MEMBRANE PHOSPHOLIPIDS

被引:44
作者
KNAUER, MF
LONGMUIR, KJ
YAMAMOTO, RS
FITZGERALD, TP
GRANGER, GA
机构
[1] UNIV CALIF IRVINE, COLL MED, DEPT MOLEC BIOL & BIOCHEM, IRVINE, CA 92717 USA
[2] UNIV CALIF IRVINE, COLL MED, DEPT PHYSIOL & BIOPHYS, IRVINE, CA 92717 USA
关键词
D O I
10.1002/jcp.1041420305
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The role of phospholipase (PLase) activation and lipid metabolism in lymphotoxin (LT)‐ and tumor necrosis factor (TNF)‐mediated destruction of murine L929 cells was examined. At the levels of LT and TNF employed, cell destruction began at 4–6 h and was 99% complete by 30 h. Cell membrane phospholipids (PL), labelled in situ at the C2 position with 14C arachidonic acid, were analyzed by two‐dimensional thin‐layer chromatography and quantiated over a 30 h time course after LT or TNF treatment. The ratio of radiolabel incorporation relative to the actual amount of each PL present was determined by inorganic phosphate analysis. Radiolabelled arachidonic acid, eicosanoids, and neutral lipids were released into the medium prior to the onset of cell death (4–6 h) and continued to accumulate linearly throughout the destructive reaction. There was a quantitative relationship between the appearance of radiolabelled metabolites in the media and the loss of radiolabelled cellular PL. Cellular phosphatidylethanola‐mine was the primary PL deacylated by PLase action, showing a 75% reduction in radiolabel. The PLase inhibitors—quinacrine, hydrocortisone, dexamethasone, and indomethacin—were potent inhibitors of LT‐ and TNF‐mediated cell destruction, suggesting that selective deacylation of specific membrane PL by PLase activation is an important step in the events that lead to LT‐ and TNF‐mediated cellular destruction in vitro. Copyright © 1990 Wiley‐Liss, Inc.
引用
收藏
页码:469 / 479
页数:11
相关论文
共 41 条
[1]   A POSSIBLE ROLE OF GLUCOCORTICOIDS - AN INTRINSIC INHIBITOR OF THE CYTO-TOXIC ACTIVITY OF TUMOR NECROSIS FACTOR [J].
ABE, S ;
YAMAMOTO, T ;
IIHARA, S ;
YAMAZAKI, M ;
MIZUNO, D .
JAPANESE JOURNAL OF CANCER RESEARCH, 1988, 79 (03) :305-308
[2]   CHARACTERIZATION OF RECEPTORS FOR HUMAN-TUMOR NECROSIS FACTOR AND THEIR REGULATION BY GAMMA-INTERFERON [J].
AGGARWAL, BB ;
EESSALU, TE ;
HASS, PE .
NATURE, 1985, 318 (6047) :665-667
[3]  
BAGLIONI C, 1985, J BIOL CHEM, V260, P3395
[4]   ARACHIDONIC ACID-INDUCED RELEASE OF CALCIUM IN PERMEABILIZED HUMAN-NEUTROPHILS [J].
BEAUMIER, L ;
FAUCHER, N ;
NACCACHE, PH .
FEBS LETTERS, 1987, 221 (02) :289-292
[5]   STIMULATION OF BONE-RESORPTION AND INHIBITION OF BONE-FORMATION INVITRO BY HUMAN-TUMOR NECROSIS FACTORS [J].
BERTOLINI, DR ;
NEDWIN, GE ;
BRINGMAN, TS ;
SMITH, DD ;
MUNDY, GR .
NATURE, 1986, 319 (6053) :516-518
[6]   MACROCORTIN - A POLYPEPTIDE CAUSING THE ANTI-PHOSPHOLIPASE EFFECT OF GLUCOCORTICOIDS [J].
BLACKWELL, GJ ;
CARNUCCIO, R ;
DIROSA, M ;
FLOWER, RJ ;
PARENTE, L ;
PERSICO, P .
NATURE, 1980, 287 (5778) :147-149
[7]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[8]   TUMOR NECROSIS FACTOR/CACHECTIN STIMULATES PERITONEAL-MACROPHAGES, POLYMORPHONUCLEAR NEUTROPHILS, AND VASCULAR ENDOTHELIAL-CELLS TO SYNTHESIZE AND RELEASE PLATELET-ACTIVATING-FACTOR [J].
CAMUSSI, G ;
BUSSOLINO, F ;
SALVIDIO, G ;
BAGLIONI, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (05) :1390-1404
[9]  
CHANG J, 1986, J IMMUNOL, V136, P1283
[10]   TUMOR NECROSIS FACTOR (CACHECTIN) INDUCES PHOSPHOLIPASE-A2 ACTIVITY AND SYNTHESIS OF A PHOSPHOLIPASE-A2-ACTIVATING PROTEIN IN ENDOTHELIAL-CELLS [J].
CLARK, MA ;
CHEN, MJ ;
CROOKE, ST ;
BOMALASKI, JS .
BIOCHEMICAL JOURNAL, 1988, 250 (01) :125-132